Absolute Quantification of Aβ(1-42) in CSF Using a Mass Spectrometric Reference Measurement Procedure

Por Pannee, Josef, Blennow, Kaj, Zetterberg, Henrik, Portelius, Erik
Publicado no J Vis Exp (2017)

The amyloid-β isoform pattern in cerebrospinal fluid in familial PSEN1 M139T- and L286P-associated Alzheimer's disease

Por PORTELIUS, ERIK, FORTEA, JUAN, MOLINUEVO, JOSE LUIS, GUSTAVSSON, MIKAEL K., ANDREASSON, ULF, SANCHEZ-VALLE, RAQUEL
Publicado em 2012

A novel Aβ isoform pattern in CSF reflects γ-secretase inhibition in Alzheimer disease

Por Portelius, Erik, Dean, Robert A, Gustavsson, Mikael K, Andreasson, Ulf, Zetterberg, Henrik, Siemers, Eric, Blennow, Kaj
Publicado em 2010

APLP1 as a cerebrospinal fluid biomarker for γ-secretase modulator treatment

Por Sjödin, Simon, Andersson, Kerstin K. A., Mercken, Marc, Zetterberg, Henrik, Borghys, Herman, Blennow, Kaj, Portelius, Erik
Publicado no Alzheimers Res Ther (2015)

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease

Por Mattsson, Niklas, Insel, Philip S, Palmqvist, Sebastian, Portelius, Erik, Zetterberg, Henrik, Weiner, Michael, Blennow, Kaj, Hansson, Oskar
Publicado no EMBO Mol Med (2016)

CSF neurofilament light concentration is increased in presymptomatic CHMP2B mutation carriers

Por Rostgaard, Nina, Roos, Peter, Portelius, Erik, Blennow, Kaj, Zetterberg, Henrik, Simonsen, Anja H., Nielsen, Jørgen E.
Publicado no Neurology (2018)

Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer’s disease

Por Portelius, Erik, Bogdanovic, Nenad, Gustavsson, Mikael K., Volkmann, Inga, Brinkmalm, Gunnar, Zetterberg, Henrik, Winblad, Bengt, Blennow, Kaj
Publicado em 2010

Astroglial activation and altered amyloid metabolism in human repetitive concussion

Por Shahim, Pashtun, Tegner, Yelverton, Marklund, Niklas, Höglund, Kina, Portelius, Erik, Brody, David L., Blennow, Kaj, Zetterberg, Henrik
Publicado no Neurology (2017)

Site-specific characterization of threonine, serine, and tyrosine glycosylations of amyloid precursor protein/amyloid β-peptides in human cerebrospinal fluid

Por Halim, Adnan, Brinkmalm, Gunnar, Rüetschi, Ulla, Westman-Brinkmalm, Ann, Portelius, Erik, Zetterberg, Henrik, Blennow, Kaj, Larson, Göran, Nilsson, Jonas
Publicado em 2011

Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression

Por Zetterberg, Henrik, Skillbäck, Tobias, Mattsson, Niklas, Trojanowski, John Q., Portelius, Erik, Shaw, Leslie M., Weiner, Michael W., Blennow, Kaj
Publicado no JAMA Neurol (2016)

Effect of physical exercise on markers of neuronal dysfunction in cerebrospinal fluid in patients with Alzheimer's disease

Por Jensen, Camilla Steen, Portelius, Erik, Høgh, Peter, Wermuth, Lene, Blennow, Kaj, Zetterberg, Henrik, Hasselbalch, Steen Gregers, Simonsen, Anja Hviid
Publicado no Alzheimers Dement (N Y) (2017)

Confounding Factors Influencing Amyloid Beta Concentration in Cerebrospinal Fluid

Por Bjerke, Maria, Portelius, Erik, Minthon, Lennart, Wallin, Anders, Anckarsäter, Henrik, Anckarsäter, Rolf, Andreasen, Niels, Zetterberg, Henrik, Andreasson, Ulf, Blennow, Kaj
Publicado em 2010

Increased CSF neurogranin concentration is specific to Alzheimer disease

Por Wellington, Henrietta, Paterson, Ross W., Portelius, Erik, Törnqvist, Ulrika, Magdalinou, Nadia, Fox, Nick C., Blennow, Kaj, Schott, Jonathan M., Zetterberg, Henrik
Publicado no Neurology (2016)

Phenotypic Screening Identifies Modulators of Amyloid Precursor Protein Processing in Human Stem Cell Models of Alzheimer’s Disease

Por Brownjohn, Philip W., Smith, James, Portelius, Erik, Serneels, Lutgarde, Kvartsberg, Hlin, De Strooper, Bart, Blennow, Kaj, Zetterberg, Henrik, Livesey, Frederick J.
Publicado no Stem Cell Reports (2017)

Tau oligomers in cerebrospinal fluid in Alzheimer's disease

Por Sengupta, Urmi, Portelius, Erik, Hansson, Oskar, Farmer, Kathleen, Castillo‐Carranza, Diana, Woltjer, Randall, Zetterberg, Henrik, Galasko, Douglas, Blennow, Kaj, Kayed, Rakez
Publicado no Ann Clin Transl Neurol (2017)

Effects of γ-Secretase Inhibition on the Amyloid β Isoform Pattern in a Mouse Model of Alzheimer's Disease

Por Portelius, Erik, Zhang, Bin, Gustavsson, Mikael K., Brinkmalm, Gunnar, Westman-Brinkmalm, Ann, Zetterberg, Henrik, Lee, Virginia M.-Y., Trojanowski, John Q., Blennow, Kaj
Publicado em 2010

Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer’s disease

Por Portelius, Erik, Zetterberg, Henrik, Skillbäck, Tobias, Törnqvist, Ulrika, Andreasson, Ulf, Trojanowski, John Q., Weiner, Michael W., Shaw, Leslie M., Mattsson, Niklas, Blennow, Kaj
Publicado no Brain (2015)

Pyroglutamate Amyloid β (Aβ) Aggravates Behavioral Deficits in Transgenic Amyloid Mouse Model for Alzheimer Disease

Por Wittnam, Jessica L., Portelius, Erik, Zetterberg, Henrik, Gustavsson, Mikael K., Schilling, Stephan, Koch, Birgit, Demuth, Hans-Ulrich, Blennow, Kaj, Wirths, Oliver, Bayer, Thomas A.
Publicado em 2012

Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer’s disease

Por Hellwig, Konstantin, Kvartsberg, Hlin, Portelius, Erik, Andreasson, Ulf, Oberstein, Timo Jan, Lewczuk, Piotr, Blennow, Kaj, Kornhuber, Johannes, Maler, Juan Manuel, Zetterberg, Henrik, Spitzer, Philipp
Publicado no Alzheimers Res Ther (2015)

The aqueous phase of Alzheimer’s disease brain contains assemblies built from ~4 and ~7 kDa Aβ species

Por Mc Donald, Jessica M., O’Malley, Tiernan T., Liu, Wen, Mably, Alexandra J., Brinkmalm, Gunnar, Portelius, Erik, Wittbold, William M., Frosch, Matthew P., Walsh, Dominic M.
Publicado no Alzheimers Dement (2015)